4//SEC Filing
Meeker David P 4
Accession 0001104659-24-036316
CIK 0001649904other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:54 PM ET
Size
5.6 KB
Accession
0001104659-24-036316
Insider Transaction Report
Form 4
Meeker David P
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-03-19$39.22/sh−45,494$1,784,275→ 174,605 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $39.04 to $39.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001385155
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 8:54 PM ET
- Size
- 5.6 KB